JP2023542950A5 - - Google Patents
Info
- Publication number
- JP2023542950A5 JP2023542950A5 JP2023518378A JP2023518378A JP2023542950A5 JP 2023542950 A5 JP2023542950 A5 JP 2023542950A5 JP 2023518378 A JP2023518378 A JP 2023518378A JP 2023518378 A JP2023518378 A JP 2023518378A JP 2023542950 A5 JP2023542950 A5 JP 2023542950A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063082208P | 2020-09-23 | 2020-09-23 | |
| US63/082,208 | 2020-09-23 | ||
| PCT/US2021/051758 WO2022066911A1 (en) | 2020-09-23 | 2021-09-23 | Compositions and methods for inhibiting alpha-synuclein aggregation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023542950A JP2023542950A (ja) | 2023-10-12 |
| JP2023542950A5 true JP2023542950A5 (https=) | 2024-10-02 |
| JPWO2022066911A5 JPWO2022066911A5 (https=) | 2024-10-02 |
Family
ID=80845817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518378A Pending JP2023542950A (ja) | 2020-09-23 | 2021-09-23 | α－シヌクレインの凝集を阻害するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240025953A1 (https=) |
| EP (1) | EP4216978A4 (https=) |
| JP (1) | JP2023542950A (https=) |
| CN (1) | CN116457466A (https=) |
| AU (1) | AU2021349261A1 (https=) |
| CA (1) | CA3192936A1 (https=) |
| WO (1) | WO2022066911A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116590342B (zh) * | 2023-05-11 | 2026-04-03 | 普递瑞(上海)医药有限公司 | 一种aav载体及其应用 |
| WO2024229777A1 (zh) * | 2023-05-11 | 2024-11-14 | 深圳先进技术研究院 | 一种aav载体及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1680145A4 (en) * | 2003-10-14 | 2007-05-23 | Neurologix Res Inc | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES |
| EP2154969B1 (en) * | 2007-05-16 | 2015-11-18 | The Brigham and Women's Hospital, Inc. | Treatment of synucleinopathies |
| JP2016503405A (ja) * | 2012-11-05 | 2016-02-04 | ジェンザイム・コーポレーション | タンパク質症を処置するための組成物および方法 |
| US20170184612A1 (en) * | 2014-04-09 | 2017-06-29 | The Trustees Of Columbia University In The City Of New York | Use of leukocytes and novel biomarkers in the diagnosis, confirmation, and treatment of a neurological disorder |
| KR102423442B1 (ko) * | 2015-12-11 | 2022-07-20 | 캘리포니아 인스티튜트 오브 테크놀로지 | 아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드 |
| CA3029676A1 (en) * | 2016-06-29 | 2018-01-04 | The Regents Of The University Of California | Structure-based peptide inhibitors of alpha-synuclein aggregation |
| WO2019036673A1 (en) * | 2017-08-18 | 2019-02-21 | The Medical College Of Wisconsin, Inc. | THERAPY BASED ON SRCP1 FOR DISEASES ASSOCIATED WITH PROTEIN AGGREGATION |
| WO2019068854A1 (en) * | 2017-10-06 | 2019-04-11 | Ospedale San Raffaele S.R.L. | GENE THERAPY OF NEURODEGENERATIVE DISEASES USING VAA VECTORS |
| CA3096293A1 (en) * | 2018-04-27 | 2019-10-31 | Rocket Pharmaceuticals, Ltd. | Gene therapy for cns degeneration |
| CA3118692A1 (en) * | 2018-11-06 | 2020-05-14 | Alsatech, Inc. | Cell-based gene therapy for neurodegenerative diseases |
-
2021
- 2021-09-23 WO PCT/US2021/051758 patent/WO2022066911A1/en not_active Ceased
- 2021-09-23 CN CN202180070652.0A patent/CN116457466A/zh active Pending
- 2021-09-23 US US18/027,250 patent/US20240025953A1/en active Pending
- 2021-09-23 CA CA3192936A patent/CA3192936A1/en active Pending
- 2021-09-23 JP JP2023518378A patent/JP2023542950A/ja active Pending
- 2021-09-23 AU AU2021349261A patent/AU2021349261A1/en active Pending
- 2021-09-23 EP EP21873431.7A patent/EP4216978A4/en active Pending